Jeffrey Newcorn

Dr. Jeffrey Newcorn is Associate Professor of Psychiatry and Pediatrics and Director of the Division of Child and Adolescent Psychiatry at Mount Sinai Medical Center in New York. Dr. Newcorn’s work spans both clinical and translational topics. He is a member of the steering committee of the NIMH-funded multicenter study “Multimodal Treatment of Children with ADHD (MTA).” He was a member of the DSM-IV advisory committees on child and adolescent disorders and disruptive behavior disorders. He is the primary investigator on an NIMH-funded ADHD Research Infrastructure Network devoted to understanding the neurobiology of ADHD and is the principal investigator or co-investigator on several NIMH-funded grants that examine the clinical, genetic, neuroanatomic, and neurophysiologic basis of ADHD its treatment. He is an editorial board member of several leading child psychiatry and psychology journals. Dr. Newcorn directs an active clinical trials program and has studied many of the newer medication treatments for ADHD. He has published over 150 peer-reviewed articles and book chapters on these and related subjects. He received his undergraduate and medical degrees from the University of Rochester. He completed his general psychiatry and child and adolescent psychiatry training at Tufts-New England Medical Center.